🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a single arm, open label pilot to test the combination of dapa...
Status
Unknown
Location
Saint Luke's Cancer Institute
Start Date
2021-08-25
Trial ID
NCT05025735
Treatments Being Tested
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Status
Recruiting
Location
Ellison Clinic at Saint John's
Start Date
2023-04-17
Trial ID
NCT05768139
The purpose of this clinical trial is to study of the molecular features of...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2018-02-02
Trial ID
NCT03439046
Treatments Being Tested
The purpose of this study is to provide post-trial access to alpelisib and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01-01
Trial ID
NCT07679269
Treatments Being Tested
The study was designed to identify and register practical observations and ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2022-03-08
Trial ID
NCT04862143
Treatments Being Tested
The purpose of this study to find out whether a very low carbohydrate diet ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2021-10-08
Trial ID
NCT05090358
Treatments Being Tested
The primary objective is to evaluate whether treatment with alpelisib in co...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2021-01-20
Trial ID
NCT04544189
Treatments Being Tested
Phase IB/II clinical trial of Alpelisb and Tucatinib in patients with PIK3C...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2022-08-25
Trial ID
NCT05230810
Treatments Being Tested
A assessment of the efficacy of first-/second-line endocrine therapies ± ta...
Status
Unknown
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2021-01-01
Trial ID
NCT04852081
Treatments Being Tested
Phase 1/2, open-label study of ETX-636 in participants with advanced solid ...
Status
Recruiting
Location
Hoag Memorial Hospital Presbyterian
Start Date
2025-06-10
Trial ID
NCT06993844